Futures on the Dow were significantly worse than the S&P 500 because of a cardiovascular drug’s late-stage setback.
Related stories
Aldi boss says some loyalty discounts 'dupe' customers
UK tries to stop Trump's diesel export ban
Micron has a chance to set the record straight with its earnings report
Nvidia is right: Its stock is a bargain by this measure
Meta launches enterprise AI business seeking to cash in on vast spending
Nvidia unveils security platform to rein in AI agents and $150bn stock buyback